Jorge Alberto Rodríguez González

Dr. Jorge Alberto Rodríguez González


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2006 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
AAAhmed Aloulou
Ahmed Aloulou
JGJorge Alberto Rodríguez González
Jorge Alberto Rodríguez González
SFSylvie Fernandez
Sylvie Fernandez
DODirk van Oosterhout
Dirk van Oosterhout
DPDelphine Puccinelli
Delphine Puccinelli
FCFrédéric Carriere
Frédéric Carriere

1 September 2006 in Enzyme and Microbial Technology
Verified
Journal Article
Closed access
Juan Carlos Mateos-DíazJuan Carlos Mateos-Díaz
Juan Carlos Mateos-Díaz
JGJorge Alberto Rodríguez González
Jorge Alberto Rodríguez González
SRS. Roussos
S. Roussos
JCJ. Cordova
J. Cordova
Abdelkarim ABOUSALHAMAbdelkarim ABOUSALHAM
Abdelkarim ABOUSALHAM
JBJ. Baratti
J. Baratti

1 November 2006 in Process Biochemistry
Verified
Journal Article
Closed access
JGJorge Alberto Rodríguez González
Jorge Alberto Rodríguez González
Juan Carlos Mateos-DíazJuan Carlos Mateos-Díaz
Juan Carlos Mateos-Díaz
JNJ. Nungaray
J. Nungaray
VGV. González
V. González
TBT. Bhagnagar
T. Bhagnagar
JBJ. Baratti
J. Baratti

1 February 2007 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
AAAhmed Aloulou
Ahmed Aloulou
JGJorge Alberto Rodríguez González
Jorge Alberto Rodríguez González
DPDelphine Puccinelli
Delphine Puccinelli
NMNicolas Mouz
Nicolas Mouz
JLJulien Leclaire
Julien Leclaire
FCFrédéric Carriere
Frédéric Carriere

9 December 2008 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
FYF. Yang
F. Yang
YWY. Wang
Y. Wang
LSL. Sternfeld
L. Sternfeld
JGJorge Alberto Rodríguez González
Jorge Alberto Rodríguez González
CRC. Ross
C. Ross
ISI. Schulz
I. Schulz

20 October 2008 in Gut
Verified
Journal Article
Closed access
PDF file
YWY Wang
Y Wang
LSL Sternfeld
L Sternfeld
FYF Yang
F Yang
JGJorge Alberto Rodríguez González
Jorge Alberto Rodríguez González
CRC Ross
C Ross
ISI Schulz
I Schulz
Background and aims: Recurrent pancreatitis is a common complication of severe hypertriglyceridaemia in patients with various gene mutations in lipoprotein lipase (LPL) or apolipoprotein CII. However, the exact pathogenetic mechanism has not yet been defined. Methods: Susceptibility to pancreatitis in LPL-deficient mice was compared with that of wild-type mice after intraperitoneal injections of caerulein by determination of amylase release and pancreatic pathological scores. The effect of chylomicrons and fatty acids on enzyme release, Ca2+ signalling and cell injury in isolated pancreatic acinar cells from wild-type and LPL-deficient mice was investigated. Results: Caerulein induced higher levels of serum amylase and more severe inflammation in the pancreas of LPL-deficient mice than in wild-type mice. Addition of free fatty acids or chylomicrons to isolated pancreatic acinar cells led to the release of amylase and caused cell injury at higher concentrations. The effect of chylomicrons was partially blocked by orlistat, an inhibitor of pancreatic lipase. These results suggest that increased concentrations of free fatty acids from chylomicron hydrolysis by pancreatic lipase can induce acinar cell injury. Surprisingly, pancreatic lipase, whether in its active or inactive state could act like an agonist by inducing amylase secretion without cell injury. It caused an increase in cGMP levels and conversion of cell-damaging sustained elevations of [Ca2+] to normal Ca2+ oscillations. Conclusions: LPL-deficient mice with severe hypertriglyceridaemia display enhanced susceptibility to acute pancreatitis. High levels of chylomicrons and free fatty acids result in pancreatic cell injury. Pancreatic lipase has a dual effect: generating free fatty acids from chylomicrons and preventing Ca2+ overload in pancreatic acinar cells.